nsMRAs: what emerging trials tell us about the future of heart failure therapy

18 May 2025 (15:28 - 15:36)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Welcome and introduction

Professor M. Cikes (Zagreb, HR)

Presentation thumbnail

Improving outcomes for the heart and kidney: the role of mineralocorticoid receptor antagonists (MRAs)

Professor B. Bozkurt (Houston, US)

Presentation thumbnail

MRAs in heart failure with reduced rejection fraction (HFrEF): a cornerstone of guideline-recommended medical therapy

Professor M. Cikes (Zagreb, HR)

Presentation thumbnail

Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

Professor J. Butler (Dallas, US)

Presentation thumbnail

Panel discussion and conclusion

Access the full session

Session thumbnail

Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation

The Event

Event poster

Heart Failure 2025

18 May 2025 15:28 CET

You may be interested in

Congress Presentation

Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

Congress Presentation

Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?

Congress Session

Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources